ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/23 | 3,155 | 3,170 | 3,150 | 3,155 | -10 | -0.3% | 67,800 |
2020/10/22 | 3,185 | 3,195 | 3,155 | 3,165 | -55 | -1.7% | 94,000 |
2020/10/21 | 3,215 | 3,260 | 3,215 | 3,220 | +20 | +0.6% | 122,600 |
2020/10/20 | 3,225 | 3,230 | 3,200 | 3,200 | -10 | -0.3% | 128,100 |
2020/10/19 | 3,180 | 3,240 | 3,170 | 3,210 | +55 | +1.7% | 161,600 |
2020/10/16 | 3,130 | 3,170 | 3,120 | 3,155 | -45 | -1.4% | 153,200 |
2020/10/15 | 3,235 | 3,240 | 3,185 | 3,200 | -70 | -2.1% | 150,600 |
2020/10/14 | 3,270 | 3,305 | 3,260 | 3,270 | -40 | -1.2% | 170,500 |
2020/10/13 | 3,300 | 3,325 | 3,270 | 3,310 | +10 | +0.3% | 136,900 |
2020/10/12 | 3,310 | 3,315 | 3,265 | 3,300 | -40 | -1.2% | 140,400 |
2020/10/09 | 3,335 | 3,365 | 3,295 | 3,340 | +5 | +0.1% | 156,900 |
2020/10/08 | 3,340 | 3,350 | 3,295 | 3,335 | ±0 | ±0% | 160,000 |
2020/10/07 | 3,310 | 3,350 | 3,290 | 3,335 | -5 | -0.1% | 193,200 |
2020/10/06 | 3,305 | 3,365 | 3,290 | 3,340 | +35 | +1.1% | 164,500 |
2020/10/05 | 3,305 | 3,350 | 3,285 | 3,305 | +55 | +1.7% | 149,900 |
2020/10/02 | 3,275 | 3,285 | 3,210 | 3,250 | - | - | 293,300 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 3,360 | 3,360 | 3,275 | 3,275 | -65 | -1.9% | 202,800 |
2020/09/29 | 3,335 | 3,350 | 3,265 | 3,340 | -30 | -0.9% | 203,500 |
2020/09/28 | 3,325 | 3,375 | 3,320 | 3,370 | +80 | +2.4% | 297,400 |
2020/09/25 | 3,300 | 3,350 | 3,280 | 3,290 | +10 | +0.3% | 297,600 |
2020/09/24 | 3,270 | 3,325 | 3,260 | 3,280 | -5 | -0.2% | 231,200 |
2020/09/23 | 3,250 | 3,350 | 3,225 | 3,285 | -65 | -1.9% | 237,000 |
2020/09/18 | 3,325 | 3,375 | 3,275 | 3,350 | +20 | +0.6% | 313,600 |
2020/09/17 | 3,275 | 3,345 | 3,260 | 3,330 | +40 | +1.2% | 226,700 |
2020/09/16 | 3,245 | 3,310 | 3,235 | 3,290 | +50 | +1.5% | 295,700 |
2020/09/15 | 3,250 | 3,250 | 3,195 | 3,240 | +30 | +0.9% | 190,600 |
2020/09/14 | 3,230 | 3,250 | 3,175 | 3,210 | ±0 | ±0% | 202,300 |
2020/09/11 | 3,165 | 3,230 | 3,165 | 3,210 | +115 | +3.7% | 309,500 |
2020/09/10 | 3,000 | 3,130 | 2,993 | 3,095 | +116 | +3.9% | 245,700 |
2020/09/09 | 2,905 | 2,983 | 2,905 | 2,979 | +39 | +1.3% | 233,100 |
2020/09/08 | 2,908 | 2,940 | 2,892 | 2,940 | +36 | +1.2% | 91,200 |
2020/09/07 | 2,887 | 2,922 | 2,886 | 2,904 | +11 | +0.4% | 156,800 |
2020/09/04 | 2,880 | 2,899 | 2,864 | 2,893 | -35 | -1.2% | 160,000 |
2020/09/03 | 2,951 | 2,964 | 2,918 | 2,928 | -13 | -0.4% | 211,600 |
2020/09/02 | 2,889 | 2,941 | 2,888 | 2,941 | -39 | -1.3% | 249,900 |
2020/09/01 | 3,010 | 3,010 | 2,960 | 2,980 | -30 | -1% | 128,400 |
2020/08/31 | 3,015 | 3,045 | 2,998 | 3,010 | +21 | +0.7% | 111,200 |
2020/08/28 | 3,010 | 3,040 | 2,963 | 2,989 | -8 | -0.3% | 135,300 |
2020/08/27 | 2,998 | 3,020 | 2,985 | 2,997 | +14 | +0.5% | 98,900 |
2020/08/26 | 2,975 | 2,990 | 2,947 | 2,983 | -22 | -0.7% | 92,900 |
2020/08/25 | 3,035 | 3,040 | 2,985 | 3,005 | +17 | +0.6% | 129,300 |
2020/08/24 | 2,969 | 2,998 | 2,949 | 2,988 | +11 | +0.4% | 87,900 |
2020/08/21 | 2,978 | 2,997 | 2,968 | 2,977 | +6 | +0.2% | 123,800 |
2020/08/20 | 2,919 | 2,979 | 2,914 | 2,971 | +38 | +1.3% | 178,700 |
2020/08/19 | 2,909 | 2,936 | 2,900 | 2,933 | +18 | +0.6% | 85,800 |
2020/08/18 | 2,900 | 2,930 | 2,877 | 2,915 | +34 | +1.2% | 100,300 |
2020/08/17 | 2,903 | 2,910 | 2,877 | 2,881 | -32 | -1.1% | 77,500 |
2020/08/14 | 2,943 | 2,943 | 2,912 | 2,913 | -59 | -2% | 128,500 |
2020/08/13 | 2,983 | 2,985 | 2,942 | 2,972 | +48 | +1.6% | 205,400 |
1001~
1050
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 273,800円 | +56.7% | +357.2% | 0.00% | 25.35倍 | 6.04倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム